adenoidal hypertrophy
Conditions
Interventions
Hormone nasal drops group:Fluticasone propionate nasal drip and oral montelukant sodium chewing tablets
Saline nasal drops group:Nasal saline drops and oral Montelukast sodium chewable tablets
Sponsors
5th Hospital Affiliated with Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
4 Years to 14 Years
Inclusion criteria
Inclusion criteria: The subject (legal representative) must voluntarily participate in the study and comply with the study regulations, understand and comply with the follow-up plan, correctly record the scale score, medication status and adverse events, and voluntarily sign a written informed consent; Children aged 4-14 years and diagnosed with simple adenoid hypertrophy without tonsillar hypertrophy; He had never undergone tonsillectomy or adenoidectomy previously.
Exclusion criteria
Exclusion criteria: Children who are completely unable to cooperate with them by using nasal drops; History of severe congenital cardiovascular and cerebrovascular diseases, thalassemia, broad bean disease and other diseases; People with a family history of inherited diseases, mental retardation or dementia, brain organic mental disorders, or other mental disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoid size;The OSA-18 scale;Determination of blood corticotropin hormone; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine blood test;C reactive protein ; | — |
Countries
China
Contacts
Public ContactHong Haiyu
5th Hospital Affiliated with Sun Yat-sen University
Outcome results
None listed